STOCK TITAN

Lilly Endowment reports 90.4M Eli Lilly (LLY) shares, a 9.6% stake

(Moderate)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Lilly Endowment, Inc., an Indiana not-for-profit private foundation described under Section 501(c)(3) and classified as a private foundation under Section 509(a), reports beneficial ownership of 90,376,978 shares of Eli Lilly and Company common stock as of June 30, 2026.

This position represents 9.6% of Eli Lilly's common stock, based on 941,741,406 shares outstanding as of April 27, 2026, as reported in Eli Lilly's Form 10-Q for the period ended March 31, 2026. Lilly Endowment has sole voting power and sole dispositive power over all 90,376,978 shares, with no shared voting or dispositive power.

Positive

  • None.

Negative

  • None.
Shares beneficially owned 90,376,978 shares Eli Lilly common stock beneficially owned by Lilly Endowment, Inc. as of June 30, 2026
Ownership percentage 9.6% Percentage of Eli Lilly common stock class represented by Lilly Endowment’s holdings
Shares outstanding baseline 941,741,406 shares Eli Lilly common stock outstanding as of April 27, 2026, per Form 10-Q
Sole voting power 90,376,978 shares Shares over which Lilly Endowment, Inc. has sole power to vote or direct the vote
Sole dispositive power 90,376,978 shares Shares over which Lilly Endowment, Inc. has sole power to dispose or direct disposition
beneficially owned financial
"Amount beneficially owned: 90,376,978 shares as of June 30, 2026"
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
sole voting power financial
"Sole Voting Power 90,376,978.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
sole dispositive power financial
"Sole Dispositive Power 90,376,978.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
private foundation financial
"and is a private foundation under Section 509(a) of the Code"
Section 501(c)(3) financial
"an organization described in Section 501(c)(3) of the Internal Revenue Code"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What percentage of Eli Lilly (LLY) does Lilly Endowment, Inc. own according to this Schedule 13G/A?

Lilly Endowment, Inc. reports beneficial ownership of 9.6% of Eli Lilly’s common stock. This percentage is based on 941,741,406 shares outstanding as of April 27, 2026, as disclosed in Eli Lilly’s Form 10-Q.

How many Eli Lilly (LLY) shares are beneficially owned by Lilly Endowment, Inc.?

Lilly Endowment, Inc. beneficially owns 90,376,978 shares of Eli Lilly common stock. All of these shares are reported as of June 30, 2026 and are held without any right-to-acquire component.

What voting and dispositive powers does Lilly Endowment, Inc. hold over its Eli Lilly (LLY) shares?

Lilly Endowment, Inc. has sole voting power over 90,376,978 shares and sole dispositive power over the same number. It reports no shared voting and no shared dispositive power over Eli Lilly shares.

How was the 9.6% ownership of Eli Lilly (LLY) by Lilly Endowment, Inc. calculated?

The 9.6% stake is calculated using 941,741,406 Eli Lilly common shares outstanding as of April 27, 2026. That outstanding share figure comes from Eli Lilly’s Form 10-Q for the quarter ended March 31, 2026.

What is Lilly Endowment, Inc., the reporting holder of Eli Lilly (LLY) shares on this Schedule 13G/A?

Lilly Endowment, Inc. is a not-for-profit corporation organized in Indiana and described in Section 501(c)(3) of the Internal Revenue Code. It is classified as a private foundation under Section 509(a).

As of what date is Lilly Endowment, Inc.’s ownership position in Eli Lilly (LLY) reported?

Lilly Endowment, Inc.’s beneficial ownership of 90,376,978 shares, representing 9.6% of Eli Lilly’s common stock, is reported as of June 30, 2026, using the issuer’s outstanding share count from April 27, 2026.





532457108

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage of class represented is based on 941,741,406 shares of common stock outstanding as of April 27, 2026 (the most recent date for which such information is publicly available), as reported in the Issuer's Form 10-Q for the period ended March 31, 2026. This information is provided as of June 30, 2026.


SCHEDULE 13G



LILLY ENDOWMENT, INC.
Signature:Diane M. Stenson
Name/Title:Vice President and Treasurer
Date:07/23/2026